Actively Recruiting
Metagenomic Analysis of Bacterial Microbiota in Breast Milk
Led by Centre Hospitalier Sud Francilien · Updated on 2025-12-16
120
Participants Needed
1
Research Sites
172 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to determine the extent to which bacteria in the breast milk microbiota represent an infectious risk for premature infants, by investigating whether they possess virulence genes, and if so, whether these are expressed or repressed.
CONDITIONS
Official Title
Metagenomic Analysis of Bacterial Microbiota in Breast Milk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women of legal age who have given birth at the CHSF or another establishment and whose newborn(s) are cared for in the CHSF's Neonatal Medicine and Intensive Care Unit
- Women wishing to give their milk to their child
- Parents who have consented for the mother-child pair to participate in the study
You will not qualify if you...
- Mother who received antibiotic therapy in the 3 months before delivery, except for injectable antibiotic prophylaxis during delivery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France, 91106
Actively Recruiting
Research Team
D
Didier LECOINTE, PharmD
CONTACT
C
Caroline TOURTE
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here